Last reviewed: June 17, 2026
Last updated: June 17, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, the active ingredient in Wegovy, works by slowing stomach emptying and signaling fullness to your brain, triggering appetite reduction. Clinical trials show that patients using semaglutide lose weight progressively over time, with the most significant changes occurring between months 2 and 6. Understanding your realistic weight loss timeline helps you stay motivated and set sustainable health goals.
Typical Semaglutide Weight Loss Timeline by Month
Most patients begin noticing appetite changes within the first 1-2 weeks of starting semaglutide, though visible weight loss typically appears by week 4. During the initial titration phase (weeks 1-4), your body adjusts to the medication while your dose remains low, so dramatic weight loss is not expected during this period. Many people report feeling fuller faster and losing interest in foods they previously craved.
By month 2-3, as your dose increases and your body fully responds to the medication, weight loss accelerates. Clinical data shows patients averaging 3-5 pounds per month during this window, with some losing more depending on their starting weight and lifestyle factors. This period marks the transition from initial adjustment to sustained, measurable progress.
Months 4-6 represent the peak weight loss phase for most patients, where monthly losses of 4-6 pounds are common. Total body weight reductions of 10-15% are frequently achieved by the end of month 6 in structured clinical programs. Individual results vary based on adherence, diet quality, physical activity, and genetic factors that influence peptide pathway responsiveness.
Clinical Evidence on Semaglutide Weight Loss Results
The STEP trials, which evaluated semaglutide in over 4,500 patients, demonstrated average weight loss of 9.3-15.3% of initial body weight over 68 weeks depending on dose. Patients receiving the higher maintenance doses (1.0 mg weekly) consistently outperformed those on lower doses, emphasizing the importance of reaching your therapeutic dose level. These results represent some of the most robust weight loss data available for any medication.
Long-term responders in clinical studies maintained weight loss for years when continuing semaglutide therapy, with many achieving even greater cumulative losses as time progressed. Weight loss typically plateaus after 6-12 months on a stable dose, meaning continued progress requires either consistent effort or dose optimization. PlexusDx uses the Precision Peptide Genetic Test to identify which patients may respond more dramatically to GLP-1 therapy based on genetic markers like GLP1R rs6923761, helping predict your individual timeline.
Factors That Influence Your Personal Weight Loss Speed
Your starting weight significantly impacts both the speed and magnitude of weight loss, as patients with higher initial weights often experience faster absolute losses in early months. Dietary quality matters enormously—patients combining semaglutide with whole foods and adequate protein lose more weight than those eating processed foods despite appetite suppression. Physical activity amplifies results, with patients exercising 150+ minutes weekly achieving weight loss 20-30% greater than sedentary patients on the same medication dose.
Age, metabolic health, and insulin resistance create individual variations in response. Younger patients and those with better baseline metabolic function sometimes see faster initial losses, though this is not universal. Genetic variants in your GLP-1 receptor and FTO genes influence how efficiently your body responds to semaglutide—information PlexusDx's Precision Peptide Genetic Test reveals to predict your personalized weight loss trajectory.
Medication adherence and consistency prove critical; patients who miss doses or skip weeks show delayed results compared to those maintaining weekly injections precisely as prescribed. Sleep quality, stress levels, and hormonal factors (particularly in women) also subtly affect pace, though they rarely override the medication's primary effect. Your individual optimization with PlexusDx's support ensures you're maximizing results within your unique biology.
What to Expect Beyond the First 6 Months
After reaching your therapeutic dose and experiencing 3-6 months of consistent weight loss, progress naturally slows as your body adapts to the medication and your weight decreases. This plateau is normal and does not indicate treatment failure; it reflects your body reaching a new equilibrium at the lower weight level. Many patients continue losing slowly—1-2 pounds monthly—for 6-12 additional months before stabilizing completely.
Long-term therapy (continuing semaglutide indefinitely) maintains weight loss and prevents rapid regain that typically occurs when GLP-1 therapy stops. Studies tracking patients for 2+ years show that those staying on medication sustain 85-95% of their achieved weight loss, while those discontinuing regain 50-75% within 12 months. This demonstrates that semaglutide's benefit depends on continuous use rather than being a temporary fix.
PlexusDx supports long-term success with compounded semaglutide injections priced consistently at $149/month regardless of dose—eliminating the financial barrier to extended treatment. Your price won't increase as your dose optimizes, making sustained therapy accessible. Many patients pair long-term semaglutide use with PlexusDx's Precision Peptide Genetic Test to understand their genetic predispositions (markers like GIPR rs1800437 and MC4R rs17782313) and adjust lifestyle strategies accordingly.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
When will I see my first weight loss on semaglutide?
Most patients notice appetite reduction within 1-2 weeks, but visible weight loss typically appears around week 4 as your dose increases. During the initial titration phase (weeks 1-4), changes are subtle; accelerated weight loss begins in months 2-3 when your dose reaches therapeutic levels and your body fully responds to the medication.
How much weight can I lose in the first 3 months?
Clinical data shows average weight loss of 5-10% of body weight in the first three months, which translates to roughly 10-25 pounds for someone weighing 200 pounds, depending on starting weight and individual response factors. Peak monthly losses typically occur during months 2-3 as your dose increases.
How much does PlexusDx semaglutide cost and does price change with my dose?
PlexusDx compounded semaglutide injections start at $149 per month and remain that price across all dose levels—your dose may go up, but your price won't. The medication comes from licensed 503A compounding pharmacies, requires no insurance, and is HSA/FSA eligible, making it accessible to all 50 states.
What happens to weight loss after 6 months?
Weight loss typically slows after 6 months as your body adapts, with most patients losing 1-2 pounds monthly thereafter. Continuing semaglutide prevents weight regain; studies show patients staying on treatment maintain 85-95% of their weight loss long-term, while those stopping regain 50-75% of lost weight within one year.
Can PlexusDx's genetic test predict how fast I'll lose weight?
Yes—PlexusDx's Precision Peptide Genetic Test ($99 add-on after your first month) analyzes 14 pathways and 150+ genetic insights including your GLP1R and GIPR variants, which influence how efficiently your body responds to semaglutide and predict your likely weight loss trajectory and timeline.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Is a Headache a Side Effect of Wegovy?
Is It Okay to Start Wegovy at 1.7 mg? Understanding the Right Dosage